Vladimir Zaharchook
Director/Miembro de la Junta en MEDISTEM INC .
Perfil
Vladimir Zaharchook is currently the Vice Chairman at Medistem, Inc. and Director at Nobilis Therapeutics, Inc. He has an undergraduate and graduate degree from Saint Petersburg State University of Economics.
Cargos activos de Vladimir Zaharchook
| Empresas | Cargo | Inicio |
|---|---|---|
| MEDISTEM INC | Director/Miembro de la Junta | - |
Nobilis Therapeutics, Inc.
 Nobilis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nobilis Therapeutics, Inc. develops inhalation-based therapeutics for the treatment of neurologic, psychiatric, and development disorders. It develops gas mixtures that offer reproducible, standardized, and controlled patient exposure to address unmet medical needs in psychiatric and neurological disorders, including PTSD, autism, and ADHD. The company was founded by Vlad Bogin and is headquartered in Portland, OR. | Director/Miembro de la Junta | - |
Formación de Vladimir Zaharchook.
| Saint Petersburg State University of Economics | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Medistem, Inc.
 Medistem, Inc. Medical SpecialtiesHealth Technology Medistem, Inc. is focused on developing therapies for treating serious diseases and conditions using the natural regenerative properties of stem cells. Endometrial Regenerative Cell possess specialized abilities to stimulate new blood vessel growth and can differentiate into lung, liver, heart, brain, bone, cartilage, fat and pancreatic tissue. The company was founded by Neil H. Riordan in October 2005, and is headquartered in San Diego, CA. | Health Technology |
Nobilis Therapeutics, Inc.
Nobilis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nobilis Therapeutics, Inc. develops inhalation-based therapeutics for the treatment of neurologic, psychiatric, and development disorders. It develops gas mixtures that offer reproducible, standardized, and controlled patient exposure to address unmet medical needs in psychiatric and neurological disorders, including PTSD, autism, and ADHD. The company was founded by Vlad Bogin and is headquartered in Portland, OR. | Commercial Services |
- Bolsa de valores
- Insiders
- Vladimir Zaharchook
